医学
肝移植
回顾性队列研究
儿科
存活率
器官共享联合网络
移植
内科学
外科
作者
Ulrich Baumann,Vincent Karam,René Adam,Constantino Fondevila,Anil Dhawan,Etienne Sokal,Emmanuel Jacquemin,Deirdre Kelly,Enke Grabhorn,Joanna Pawłowska,Lorenzo D'Antiga,Paloma Jara Vega,Dominique Debray,Wojciech G. Polak,Jean de Ville de Goyet,Henkjan J. Verkade
出处
期刊:Pediatrics
[American Academy of Pediatrics]
日期:2022-09-16
卷期号:150 (4)
被引量:5
标识
DOI:10.1542/peds.2022-057424
摘要
OBJECTIVES The European Liver Transplant Registry has been collecting data on virtually all pediatric liver transplant (PLT) procedures in Europe since 1968. We analyzed patient outcome over time and identified parameters associated with long-term patient outcome. METHODS Participating centers and European organ-sharing organizations provided retrospective data to the European Liver Transplant Registry. To identify trends, data were grouped into consecutive time spans: era A: before 2000, era B: 2000 to 2009, and the current era, era C: since 2010. RESULTS From June 1968 until December 2017, 16 641 PLT were performed on 14 515 children by 133 centers. The children <7 years of age represented 58% in era A, and 66% in the current era (P <.01). The main indications for PLT were congenital biliary diseases (44%) and metabolic diseases (18%). Patient survival at 5 years is currently 86% overall and 97% in children who survive the first year after PLT. The survival rate has improved from 74% in era A to 83% in era B and 85% in era C (P <.0001). Low-volume centers (<5 PLT/year) represented 75% of centers but performed only 19% of PLT and were associated with a decreased survival rate. In the current era, however, survival rates has become irrespective of volume. Infection is the leading cause of death (4.1%), followed by primary nonfunction of the graft (1.4%). CONCLUSIONS PLT has become a highly successful medical treatment that should be considered for all children with end-stage liver disease. The main challenge for further improving the prognosis remains the early postoperative period.
科研通智能强力驱动
Strongly Powered by AbleSci AI